These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 14884260

  • 1. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.
    GUTMAN AB, YU TF.
    Trans Assoc Am Physicians; 1951; 64():279-88. PubMed ID: 14884260
    [No Abstract] [Full Text] [Related]

  • 2. The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.
    BISHOP C, RAND R, TALBOTT JH.
    J Clin Invest; 1951 Aug; 30(8):889-95. PubMed ID: 14861311
    [No Abstract] [Full Text] [Related]

  • 3. Uricosuric agents in the management of chronic tophaceous gout with renal impairment.
    MORRIS JB.
    N Z Med J; 1961 Aug; 60():390-2. PubMed ID: 14476250
    [No Abstract] [Full Text] [Related]

  • 4. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
    SIROTA JH, YU TF, GUTMAN AB.
    J Clin Invest; 1952 Jul; 31(7):692-701. PubMed ID: 14938444
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of gouty arthritis.
    TALBOTT JH.
    Calif Med; 1953 Sep; 79(3):220-6. PubMed ID: 13082423
    [Abstract] [Full Text] [Related]

  • 6. The influence of p-(di-n-propylsulfamyl)-benzoic acid on the excretion of uric acid.
    PITTS FW, CHAMBERS JS.
    U S Armed Forces Med J; 1952 Aug; 3(8):1219-24. PubMed ID: 14942976
    [No Abstract] [Full Text] [Related]

  • 7. The clinical and metabolic effects of benemid in patients with gout.
    TALBOTT JH, BISHOP C, NORCROSS BM, LOCKIE LM.
    Trans Assoc Am Physicians; 1951 Aug; 64():372-7. PubMed ID: 14884273
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The uric acid-eliminating action of probenecid (benemid) in 12 cases of gout].
    COSTE F, CHABOT J, CANET L.
    Rev Rhum Mal Osteoartic; 1953 Aug; 20(8-9):632-6. PubMed ID: 13121785
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mobilization of gouty tophi by protracted use of uricosuric agents.
    YU TF, GUTMAN AB.
    Am J Med; 1951 Dec; 11(6):765-9. PubMed ID: 14902847
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Benemid, flexin and anturane as uricosuric agents.
    LAVIETES PH.
    Conn Med; 1962 Sep; 26():561-2. PubMed ID: 14462935
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uricosuric agents in the treatment of gout.
    KERSLEY GD, GIBBS AR.
    Ann Rheum Dis; 1960 Dec; 19(4):351-5. PubMed ID: 13830930
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.